Pages that link to "Item:Q2475724"
From MaRDI portal
The following pages link to Adaptive designs for selecting drug combinations based on efficacy-toxicity response (Q2475724):
Displaying 17 items.
- Sequential design for binary dose-response experiments (Q301360) (← links)
- Optimal designs for contingent response models with application to toxicity-efficacy studies (Q389259) (← links)
- Information in a two-stage adaptive optimal design (Q389442) (← links)
- Adaptive Bayesian compound designs for dose finding studies (Q434557) (← links)
- Two-stage adaptive optimal design with fixed first-stage sample size (Q454769) (← links)
- Robust designs for multivariate logistic regression (Q478485) (← links)
- Barycentric algorithm for computing D-optimal size- and cost-constrained designs of experiments (Q513974) (← links)
- Sequential D-optimal designs for generalized linear mixed models (Q622431) (← links)
- Optimal designs for response functions with a downturn (Q710822) (← links)
- The effects of adaptation on maximum likelihood inference for nonlinear models with normal errors (Q830758) (← links)
- Penalized optimal designs for dose-finding (Q1036729) (← links)
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection (Q2301071) (← links)
- Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989) (← links)
- Sequential Methods in Multi-Arm Clinical Trials (Q3068083) (← links)
- On the Choice of a Prior for Bayesian D-Optimal Designs for the Logistic Regression Model with a Single Predictor (Q5418910) (← links)
- Optimized temporal sampling designs of the Weibull growth curve with extensions to the von Bertalanffy model (Q6615743) (← links)
- Combined criteria for dose optimisation in early phase clinical trials (Q6625215) (← links)